# OnCo record paper-qian-driver-genes-outcomes-resected-pancreatic-jama-oncol-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-qian-driver-genes-outcomes-resected-pancreatic-jama-oncol-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-qian-driver-genes-outcomes-resected-pancreatic-jama-oncol-2018" ;
  schema:name "Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma"@en ;
  schema:description "In 356 patients whose pancreatic cancer was removed, the more of the four main driver genes were broken the worse the outcome, KRAS G12D was the worst allele, CDKN2A loss shortened survival, and SMAD4 status made no difference."@en ;
  schema:url <https://onco.cc/key-papers/paper-qian-driver-genes-outcomes-resected-pancreatic-jama-oncol-2018/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2017.3420>, <https://pubmed.ncbi.nlm.nih.gov/29098284/> ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2017.3420> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Qian ZR, Rubinson DA, Nowak JA, et al." ;
  onco:related <https://onco.cc/biomarkers/kras-g12d/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:targets <https://onco.cc/targets/kras/>, <https://onco.cc/targets/cdkn2a/>, <https://onco.cc/targets/smad4/>, <https://onco.cc/targets/tp53/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/>, <https://onco.cc/institutions/stanford/> ;
  onco:pathways <https://onco.cc/pathways/p53-cell-cycle/>, <https://onco.cc/pathways/ras-mapk/> ;
  onco:terms <https://onco.cc/terms/kras-mutation-subtypes/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .
